| Christensen, Hans Henrik Chrois (Samplix 201901 CFO before Exiqon 200708 CFO) |
Chief Financial Officer (CFO) |
Samplix ApS |
Denmark |
| Christensen, Jakob Mohr (Agilent 201308 VP Global Marketing at Dako) |
Sales Manager / Marketing Manager |
Agilent (Group) |
Denmark |
| Christensen, Ulf Bech (PentaBase 2006– Managing Director + Founder before Unest A/S) |
Managing Director |
PentaBase ApS |
Denmark |
| Christiansen, Claus (CCBR + Nordic Bioscience Founder + Chairman) |
Company Founder |
CCBR (Group) |
Denmark |
| Christoffersen, Lene (Agilent 2012 Communications Manager at Dako Denmark A/S) |
Public Relations Manager / Investor Relations Manager |
Agilent (Group) |
Denmark |
| Collard, Craig (Veloxis Pharmaceuticals 201911 CEO) |
Chief Executive Officer (CEO) |
Veloxis Pharmaceuticals A/S (Nasdaq OMX Copenhagen: VELO) |
Denmark |
| Conde-Knape, Karin (Novo Group 202209 SVP of Global Drug Discovery at Novo Nordisk) |
President/Director/Head Business Group/Unit/Division |
Novo Group (Group) |
Denmark |
| Coutanceau, Emmanuelle (Novo Group 201705 Novo Seeds before Auriga Partners) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Cresswell, Sue (Proxeon 200711– Marketing Communications before GE Healthcare Biacore) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
Denmark |
| Dahlén, Patrik (Immunovia 202011– CEO before NeuroSearch + Dako + BioImage + PerkinElmer) |
Chief Executive Officer (CEO) |
NeuroSearch (Group) |
Denmark |
| Dalby-Brown, William (Pcovery 201611 COO) |
Chief Operating Officer (COO) |
Pcovery ApS |
Denmark |
| Danielsen, Morten (MS-Omics 202210 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Clinical Microbiomics (Group) |
Denmark |
| deBethizy, J. Donald (Santaris Pharma 201401– CEO before Targacept CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Denmark |
| Dharmadhikari, Kartik (Novo Group 202105 Partner at Novo Growth) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Di Cesare, Silvana (CMC Biologics 201511 Director Business Development before Capsulution Nanoscience 200705 BusDev) |
Business Development Manager / Strategy Manager |
Asahi Glass (AGC) (Group) |
Denmark |
| Domdey, Anke (invest4biotech 201410 Partner before + LEO Pharma + BioXell + Boehringer) |
Consultant (economic/technology) |
invest4biotech (i4b) |
Denmark |
| Drakeman, Lisa N. (Genmab 200506 CEO) |
Chief Executive Officer (CEO) |
Genmab (Group) |
Denmark |
| Drejer, Jørgen (Aniona ApS 201111– CEO before NeuroSearch) |
Chief Executive Officer (CEO) |
Aniona ApS |
Denmark |
| Drejer, Kirsten (Symphogen 2000–201608 Founding CEO since 201609 Executive Director) |
Board member, executive |
Servier (Group) |
Denmark |
| Duarte, Ira (Veloxis Pharmaceuticals 201911 CFO) |
Chief Financial Officer (CFO) |
Veloxis Pharmaceuticals A/S (Nasdaq OMX Copenhagen: VELO) |
Denmark |
| Duch-Pedersen, Alf (Danisco 200501 CEO) |
Chief Executive Officer (CEO) |
DuPont (Group) |
Denmark |
| Dudley, Giles (BioInnovation Institute 202012 Senior Business Developer) |
Business Development Manager / Strategy Manager |
BioInnovation Institute (BII Foundation) |
Denmark |
| Dulac, Emmanuel (Zealand Pharma 201909–202203 CEO LEFT 3/22) |
Chief Executive Officer (CEO) |
Zealand Pharma (Group) |
Denmark |
| Dunsire, Deborah (Lundbeck 201809– CEO before XTuit Pharma + Forum/EnVivo Pharma + Millennium/Takeda) |
Chief Executive Officer (CEO) |
Lundbeck (Group) |
Denmark |
| Dyrberg, Thomas (Novo 201105 Senior Partner Novo Ventures) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Dyring, Charlotte (ExpreS2ion Biotechnologies 201306 CEO before Pharmexa + Kabi Pharmacia) |
Chief Executive Officer (CEO) |
Expres2ion Biotech (Group) |
Denmark |
| Eatwell, David (Genmab 2008–202002 CFO RESIGNED 3/20) |
Chief Financial Officer (CFO) |
Genmab (Group) |
Denmark |
| Ebbensgaard, Kristian (BioPhero 201809– CEO before Business Director before Novozymes) |
Chief Executive Officer (CEO) |
FMC (Group) |
Denmark |
| Edwards, Martin (Novo AS 200902 Senior Partner + Symphogen 200902 Board Chairman) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Ehrnström, Rolf (DakoCytomation 200506– Corporate VP RnD before Gyros AB) |
Research & Development Manager |
Agilent (Group) |
Denmark |
| Elling, Christian E. (Lundbeck 202204– Head of Lundbeckfonden BioCapital before Lundbeckfonden) |
Investment Manager |
Lundbeck (Group) |
Denmark |
| Engel, Aleks (Novo 201510 Asset Director at Novo A/S) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Engelsen, Ulrik (Bifodan 200812 Managing Director) |
Managing Director |
Bifodan A/S |
Denmark |
| Enghild, Jan J. (Aarhus Univ 201106 Professor Laboratory for Proteome Analysis and Protein Characterisation) |
Professor |
Aarhus University |
Denmark |
| Enlund, Ludvig (Ellab 202306 CEO) |
Chief Executive Officer (CEO) |
Novo Group (Group) |
Denmark |
| Eriksen, Peter Mørch (BioPorto 201307– CEO before Sense A/S + Medtronic) |
Chief Executive Officer (CEO) |
BioPorto (Group) |
Denmark |
| Esbensen, Kim H. (Aalborg Univ 201401 Professor + Greenland Univ 201401 Professor) |
Professor |
Aalborg University (DK) |
Denmark |
| Faber, Johan H. (Hemab 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Hemab ApS |
Denmark |
| Feldthus, Thomas (Saniona 201705 CFO before Symphogen –201103 CFO + Co-founder LEFT 3/12) |
Chief Financial Officer (CFO) |
Saniona AB (Nasdaq First North: SANION) |
Denmark |
| Fernandez, Camilo (Kaffe Bueno 202010 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Kaffe Bueno ApS |
Denmark |
| Fischer, Per (Minervax 202212 CEO) |
Chief Executive Officer (CEO) |
Minervax ApS |
Denmark |
| Flensberg, Mikael (CLC bio 201304 Director Global Partner Relations) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Denmark |
| Flintholm Jørgensen, Keld (Lundbeck 201904– EVP + CBO before Roche Global Head of Strategic Partnering) |
Chief Business Officer (CBO) |
Lundbeck (Group) |
Denmark |
| Fogh Iversen, Lars (Novo Group 202209 SVP Digital Science + Innovation at Novo Nordisk) |
President/Director/Head Business Group/Unit/Division |
Novo Group (Group) |
Denmark |
| Fogh, Jens (Zymenex 200803 CEO) |
Chief Executive Officer (CEO) |
Zymenex (Group) |
Denmark |
| Franch, Thomas (Nuevolution 201303 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Nuevolution (Group) |
Denmark |
| Franco, Alejandro (Kaffe Bueno 202010 CCO + Co-Founder) |
Chief Commercial Officer (CCO) |
Kaffe Bueno ApS |
Denmark |
| Fredtoft Søchting, Maia (Leo Pharma 202004 Global External Communciations) |
Public Relations Manager / Investor Relations Manager |
Leo Pharma (Group) |
Denmark |
| Freltoft, Torsten (Sophion 201107 CEO) |
Chief Executive Officer (CEO) |
Ratos (Group) |
Denmark |
| French, Cynthia K. (Exiqon 200807– CSO before Affymetrix Clinical Services Laboratory before Specialty Labs) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Qiagen (Group) |
Denmark |
| Friis-Mikkelsen, Martin (Saxocon 201310– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Saxocon ApS |
Denmark |
| Frisvad, Jens Christian (TU Denmark 201207 Professor at Center for Microbial Biotechnology) |
Professor |
Technical University of Denmark (DTU) |
Denmark |
| Frost, Habib (Neurescue 201610 CEO + Founder) |
Chief Executive Officer (CEO) |
Neurescue (DK) |
Denmark |
| Frost, Karen (Leo Pharma 202201 Global Communications, Public Affairs + Sustainability) |
Public Relations Manager / Investor Relations Manager |
Leo Pharma (Group) |
Denmark |
| Fuglsang, Claus Crone (Novo Group 202112 EVP of Novozymes) |
President/Director/Head Business Group/Unit/Division |
Novozymes (Group) |
Denmark |
| Gadegaard, Thomas (Bactolife 202301– SVP of Finance + Accounting) |
Chief Financial Officer (CFO) |
Bactolife A/S |
Denmark |
| Gamst, Jesper (VBM Laboratoriet A/S 201703 Managing Director + Co-Owner) |
Managing Director |
Eurofins (Group) |
Denmark |
| Genee, Hans (Biosyntia 201610 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biosyntia ApS |
Denmark |
| Gerlach, Lene (Eir Ventures 202310 Partner before Vaekstfonden) |
Partner (venture partner) |
Eir Ventures (Group) |
Denmark |
| Gersel Pedersen, Anders (Lundbeck 2000–201812 Head RnD RETIRED 12/18) |
Research & Development Manager |
Lundbeck (Group) |
Denmark |
| Ghenchev, Robert (Novo Group 201905 Director at Novo Holdings) |
President/Director/Head Business Group/Unit/Division |
Novo Group (Group) |
Denmark |
| Glerup, Simon (Draupnir Bio 202106– CSO before CEO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Draupnir Bio ApS |
Denmark |
| Goldsmith, Neil (Sundew 202009 Chairman before Evolva –200910–201707 CEO STEPPED DOWN 7/17) |
Chief Executive Officer (CEO) |
Sundew ApS |
Denmark |
| Gouliaev, Alex Haahr (Nuevolution 201205 CEO + Co-founder before NeuroSearch) |
Chief Executive Officer (CEO) |
Nuevolution (Group) |
Denmark |
| Graber, Mauricio (Chr Hansen 201904 CEO) |
Chief Executive Officer (CEO) |
Chr. Hansen (Group) |
Denmark |
| Graugaard Døssing, Morten (Novo Group 201802 Prinicpal at Novo Seeds) |
Principal (venture capital) |
Novo Group (Group) |
Denmark |
| Gredsted, Lars (Lundbeck 202310 Senior Principal at Lundbeckfonden BioCapital) |
Principal (venture capital) |
Lundbeck (Group) |
Denmark |
| Green, Lars (Novozymes 202212 CFO) |
Chief Financial Officer (CFO) |
Novozymes (Group) |
Denmark |
| Grotkjær, Thomas (Novo Group 201809 Principal at Novo Seeds) |
Principal (venture capital) |
Novo Group (Group) |
Denmark |
| Grunkin, Michael (Visiopharm 2001– Managing Director + co-founder) |
Managing Director |
Visiopharm (Group) |
Denmark |
| Grøn, Anders (Clinical Microbiomics 202110– CEO before IFF Health + Coloplast + Chr Hansen) |
Chief Executive Officer (CEO) |
Clinical Microbiomics (Group) |
Denmark |
| Grøndahl, Christian (Snipr Biome 201903 CEO + Co-Founder before Kymab + Zealand Pharma CSO + Novo Nordisk) |
Chief Executive Officer (CEO) |
Snipr Biome ApS |
Denmark |
| Gürtler, Henrik (Novo Group 201305 CEO of Novo A/S) |
Chief Executive Officer (CEO) |
Novo Group (Group) |
Denmark |
| Görlitz, Lasse (CLC bio 2010109 Director of Communications) |
public relations / investor relations |
Qiagen (Group) |
Denmark |
| Götzsche, Anders (Lundbeck 201309 CFO) |
Chief Financial Officer (CFO) |
Lundbeck (Group) |
Denmark |
| Haahr, Peter (Novo Group 201905 CFO of Novo Holdings) |
Chief Financial Officer (CFO) |
Novo Group (Group) |
Denmark |
| Hagel, Grith (2cureX 2006 Co-founder + inventor of ChemoCellomics technology) |
Company Founder |
2cureX (Group) |
Denmark |
| Halling, Peter (Fertin Pharma 202107 CEO) |
Chief Executive Officer (CEO) |
Philip Morris (Group) |
Denmark |
| Han, Xinhua (Xin) (BGI 201106 Marketing Director BGI Europe A/S) |
Sales Manager / Marketing Manager |
BGI (CN) (Group) |
Denmark |
| Hansen, Casper Tind (Embark Biotech 201911 CEO + Pcovery 201307 CEO) |
Chief Executive Officer (CEO) |
Pcovery ApS |
Denmark |
| Hansen, Christian (Nordic Biotech 2001–) |
Company Founder |
Nordic Biotech (Group) |
Denmark |
| Hansen, Johan Doré (Visiopharm 2001– CTO + co-founder) |
Chief Technology/Technical Officer (CTO) |
Visiopharm (Group) |
Denmark |
| Hansen, John Bondo (Bukwang 201511 CEO + Co-Founder of Contera PharmaApS) |
Chief Executive Officer (CEO) |
Bukwang (Group) |
Denmark |
| Hansen, Odd Erik (Glycom 202002 CEO) |
Chief Executive Officer (CEO) |
DSM (Group) |
Denmark |
| Harrison, Kenneth (Novo Group 202105 Partner at Novo Ventures) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Hauge, Elise (Lundbeck 201909– EVP People + Communication before SimCorp + Takeda + Nycomed) |
Human Resources Manager |
Lundbeck (Group) |
Denmark |
| Hausgaard, Otto Bjerg (Denmark (govt) 202010 Investment Manager at Vaekstfonden) |
Investment Manager |
Denmark (govt) |
Denmark |
| Havranek-Kosicek, Prisca (Novo Group 201803c–201908 CFO of Novozymes A/S LEFT 8/19) |
Chief Financial Officer (CFO) |
Novozymes (Group) |
Denmark |
| Hedeby, Hasse (Fida Biosystems 202403 CCO) |
Chief Commercial Officer (CCO) |
Fida Biosytems ApS |
Denmark |
| Hedegaard, Anders (Bavarian Nordic 200708– CEO) |
Chief Executive Officer (CEO) |
Bavarian Nordic (Group) |
Denmark |
| Heery, Christopher (Bavarian Nordic 201609– CMO) |
Chief Medical Officer (CMO) |
Bavarian Nordic (Group) |
Denmark |
| Heitmann, Jürgen (Novo Group 201911 at BiOrigin before Takeda + Novartis) |
n. a. |
Novo Group (Group) |
Denmark |
| Helfgott, Ludovic (Novo Nordisk 202209 EVP + Head of Rare Disease formerly AstraZeneca 201506 President Spain) |
President/Director/Head of Research Organisation/Unit |
Novo Group (Group) |
Denmark |
| Hellmann, Carsten (ALK 201701– CEO before Sanofi SVP CEO of Merial) |
Chief Executive Officer (CEO) |
ALK (Group) |
Denmark |
| Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma) |
Chief Operating Officer (COO) |
Cobo Technologies (Group) |
Denmark |
| Herrgård, Markus (BioInnovation Institute 202206 CTO) |
Chief Technology/Technical Officer (CTO) |
BioInnovation Institute (BII Foundation) |
Denmark |
| Hershkovitz, Marcia (DakoCytomation 200506 Corporate VP Human Resources) |
n. a. |
Agilent (Group) |
Denmark |
| Hesselgren, Mikkel (Denmark (govt) 202201 SVP at Vækstfonden) |
n. a. |
Denmark (govt) |
Denmark |
| Hinsby, Anders (Orphazyme 201003– CEO + co-founder before BankInvest Biomedical Venture) |
Chief Executive Officer (CEO) |
Orphazyme (Group) |
Denmark |
| Holmlin, Erik (Exiqon 200807– CCO before BD Diagnastics before GeneOhm co-founder in 2001) |
Chief Business Officer (CBO) |
Qiagen (Group) |
Denmark |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 40 41 42 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
